Am J Epidemiol 2003; 158:316-327.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Population-based Study of Non-Hodgkin Lymphoma, Histology, and Medical History among Human Immunodeficiency Virus-negative Participants in San Francisco
1 Department of Epidemiology and Biostatistics, University of California School of Medicine, San Francisco, CA.
2 Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA.
A population-based case-control study of non-Hodgkin lymphoma was conducted in the San Francisco Bay Area of California from 1988 to 1995. The study used Working Formulation histologic subtypes of non-Hodgkin lymphoma. Diffuse and immunoblastic large-cell lymphomas and all follicular lymphomas were combined to reflect two Revised European-American Lymphoma (REAL) classifications. Results were obtained from age- and sex-adjusted polytomous multivariable logistic models for 1,304 cases and 2,402 controls who were negative for human immunodeficiency virus. Statistically significant odds ratios for REAL large-cell lymphoma were decreased for receipt of five or more different vaccines (odds ratio (OR) = 0.65), use of calcium channel blockers (OR = 0.35), mononucleosis (OR = 0.55), plant allergies (OR = 0.72), and animal allergies (OR = 0.40). Odds ratios for REAL follicular lymphoma were decreased for use of nonsteroidal antiinflammatory drugs (OR = 0.67), hepatitis (OR = 0.36), and having had three or more bee or wasp stings (OR = 0.79) and were increased for heart disease (OR = 1.5). Similar elevated odds ratios for heart disease and Bacillus Calmette-Guérin vaccine and decreased odds ratios for nonsteroidal antiinflammatory drugs, plant allergies, and three or more bee or wasp stings were found for small lymphocytic lymphoma. These data provide direction for further investigation of immune function and genetic characteristics of subtypes of non-Hodgkin lymphoma in lymphomagenesis and warrant analyses in large pooled data sets.
case-control studies; hypersensitivity; infection; lymphoma, non-Hodgkin; neoplasms by histologic type; risk factors; vaccines
Abbreviations: Abbreviations: BCG, Bacillus Calmette-Guérin; HIV, human immunodeficiency virus; NHL, non-Hodgkin lymphoma; NSAIDs, nonsteroidal antiinflammatory drugs; REAL, Revised European-American Lymphoma; Th1, T helper type 1; Th2, T helper type 2.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. S. Lee, P. M. Bracci, and E. A. Holly Non-Hodgkin Lymphoma in Women: Reproductive Factors and Exogenous Hormone Use Am. J. Epidemiol., August 1, 2008; 168(3): 278 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chao and J. H. Page Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis Am. J. Epidemiol., July 8, 2008; (2008) kwn160v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ekstrom Smedby, C. M. Vajdic, M. Falster, E. A. Engels, O. Martinez-Maza, J. Turner, H. Hjalgrim, P. Vineis, A. Seniori Costantini, P. M. Bracci, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium Blood, April 15, 2008; 111(8): 4029 - 4038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Skibola, A. Nieters, P. M. Bracci, J. D. Curry, L. Agana, D. R. Skibola, A. Hubbard, N. Becker, M. T. Smith, and E. A. Holly A functional TNFRSF5 gene variant is associated with risk of lymphoma Blood, April 15, 2008; 111(8): 4348 - 4354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Wang, S. L. Slager, P. Brennan, E. A. Holly, S. De Sanjose, L. Bernstein, P. Boffetta, J. R. Cerhan, M. Maynadie, J. J. Spinelli, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph) Blood, April 15, 2007; 109(8): 3479 - 3488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bernatsky, J. L. Lee, and E. Rahme Non-Hodgkin's lymphoma--meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories Rheumatology, April 1, 2007; 46(4): 690 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Melbye, K. E. Smedby, T. Lehtinen, K. Rostgaard, B. Glimelius, L. Munksgaard, C. Schollkopf, C. Sundstrom, E. T. Chang, P. Koskela, et al. Atopy and Risk of Non-Hodgkin Lymphoma J Natl Cancer Inst, January 17, 2007; 99(2): 158 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Landgren, Y. Zhang, S. H. Zahm, P. Inskip, T. Zheng, and D. Baris Risk of Multiple Myeloma following Medication Use and Medical Conditions: A Case-Control Study in Connecticut Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2342 - 2347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Flick, K. A. Chan, P. M. Bracci, and E. A. Holly Use of Nonsteroidal Antiinflammatory Drugs and Non-Hodgkin Lymphoma: A Population-based Case-Control Study Am. J. Epidemiol., September 1, 2006; 164(5): 497 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Bracci, T. B. Dalvi, and E. A. Holly Residential history, family characteristics and non-hodgkin lymphoma, a population-based case-control study in the san francisco bay area. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1287 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Vajdic, A. E. Grulich, J. M. Kaldor, L. Fritschi, G. Benke, A. M. Hughes, A. Kricker, J. J. Turner, S. Milliken, and B. K. Armstrong Specific infections, infection-related behavior, and risk of non-hodgkin lymphoma in adults. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1102 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Clarke, D. M. Undurraga, P. J. Harasty, S. L. Glaser, L. M. Morton, and E. A. Holly Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 630 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Engels, J. R. Cerhan, M. S. Linet, W. Cozen, J. S. Colt, S. Davis, G. Gridley, R. K. Severson, and P. Hartge Immune-Related Conditions and Immune-Modulating Medications as Risk Factors for Non-Hodgkin's Lymphoma: A Case-Control Study Am. J. Epidemiol., December 15, 2005; 162(12): 1153 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Askling, L Klareskog, H Hjalgrim, E Baecklund, M Bjorkholm, and A Ekbom Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis Ann Rheum Dis, December 1, 2005; 64(12): 1765 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Chang, K. E. Smedby, H. Hjalgrim, C. Schollkopf, A. Porwit-MacDonald, C. Sundstrom, E. Tani, F. d'Amore, M. Melbye, H.-O. Adami, et al. Medication Use and Risk of Non-Hodgkin's Lymphoma Am. J. Epidemiol., November 15, 2005; 162(10): 965 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Skibola, P. M. Bracci, R. A. Paynter, M. S. Forrest, L. Agana, T. Woodage, K. Guegler, M. T. Smith, and E. A. Holly Polymorphisms and Haplotypes in the Cytochrome P450 17A1, Prolactin, and Catechol-O-Methyltransferase Genes and Non-Hodgkin Lymphoma Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2391 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Rollison, K. J. Helzlsouer, N. A. Halsey, K. V. Shah, and R. P. Viscidi Markers of Past Infection with Simian Virus 40 (SV40) and Risk of Incident Non-Hodgkin Lymphoma in a Maryland Cohort Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1448 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Skibola, M. T. Smith, P. M. Bracci, A. E. Hubbard, L. Agana, S. Chi, and E. A. Holly Polymorphisms in Ghrelin and Neuropeptide Y Genes Are Associated with Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1251 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Grulich, C. M. Vajdic, J. M. Kaldor, A. M. Hughes, A. Kricker, L. Fritschi, J. J. Turner, S. Milliken, G. Benke, and B. K. Armstrong Birth Order, Atopy, and Risk of Non-Hodgkin Lymphoma J Natl Cancer Inst, April 20, 2005; 97(8): 587 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Skibola, M. S. Forrest, F. Coppede, L. Agana, A. Hubbard, M. T. Smith, P. M. Bracci, and E. A. Holly Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma Blood, October 1, 2004; 104(7): 2155 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Skibola, E. A. Holly, M. S. Forrest, A. Hubbard, P. M. Bracci, D. R. Skibola, C. Hegedus, and M. T. Smith Body Mass Index, Leptin and Leptin Receptor Polymorphisms, and Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 779 - 786. [Abstract] [Full Text] [PDF]
|
|